Hostname: page-component-77c89778f8-gq7q9 Total loading time: 0 Render date: 2024-07-18T12:56:30.050Z Has data issue: false hasContentIssue false

P-1243 - Psychiatrists' Perceptions of the Clinical Importance, Assessment and Management of Functioning: Results of the Emea Survey in Schizophrenia

Published online by Cambridge University Press:  15 April 2020

P. Gorwood
Affiliation:
CMME, Hôpital Sainte-Anne Paris Descartes, Paris, France
G. Juckel
Affiliation:
Psychiatrie, LWL-Universitaetsklinikum der Ruhr-Universitaet Bochum, Bochum, Germany
T. Burns
Affiliation:
Department of Psychiatry, Warneford Hospital, Oxford, UK
A. Rossi
Affiliation:
Department of Experimental Medicine, University de L’Aquila, L’Aquila, Italy
L. San
Affiliation:
Sant Joan de Déu, Barcelona, Spain
P. Cherubin
Affiliation:
Janssen EMEA, Issy les Moulineaux, France
L. Hargarter
Affiliation:
Medical & Scientific Affairs, Janssen EMEA, Johnson & Johnson, Neuss, Germany
A. Schreiner
Affiliation:
Medical & Scientific Affairs, Janssen EMEA, Johnson & Johnson, Neuss, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Many patients with schizophrenia show major difficulties in performing basic social roles. Occupational and social functioning (and independent living) are considered domains of functioning. Improvement in functioning is recognized as an important aim in treatment guidelines and as an outcome by regulatory agencies.

Objectives

The Europe, Middle East and Africa (EMEA) functioning survey canvassed opinions of psychiatrists (and neurologists with psychiatric backgrounds in Germany) across the region.

Aim

To ascertain psychiatrists' perceptions of the clinical importance, assessment and management of functioning amongst their patients with schizophrenia.

Methods

The survey comprised 17 questions and was conducted from March-April 2011, in 39 EMEA countries. Respondents' demographics and their opinions regarding personal and social functioning in patients with schizophrenia were collected.

Results

Results were obtained from 3610 clinicians. Psychiatrists reported that they perceived more than two in three of their patients show impaired/very poor levels of functioning. 91% believed that personal and social functioning was an important treatment goal for patients with schizophrenia and 90% believed it was an important goal for patients' families. The majority of psychiatrists assess the personal and social functioning of their patient at each visit but 81% determine the level of functioning through clinical interview. To manage personal and social functioning in their patients, 26% of psychiatrists prefer pharmacological interventions while 47% prefer psychosocial interventions.

Conclusion

Although psychiatrists recognize that functioning is impaired/very poor in patients with schizophrenia, there is still a need to address it as a main treatment goal for patients with schizophrenia.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.